LNWTC
HALO icon

Laird Norton Wetherby Trust Company’s Halozyme HALO Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$478K Sell
7,398
-1,101
-13% -$77.6K 0.01% 703
2025
Q4 		$572K Buy
+8,499
New +$572K 0.01% 672

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laird Norton Wetherby Trust Company's HALO Position: Q1 2026 in Review

Laird Norton Wetherby Trust Company reduced its Halozyme (HALO) stake by 13% in Q1 2026, selling an estimated $77.6K and leaving 7,398 shares worth $478K. The position accounts for 0.01% of the portfolio, ranked #703.

Laird Norton Wetherby Trust Company first reported a position in HALO in Q4 2025 and has held it in 2 quarters since. The position peaked at $572K in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Laird Norton Wetherby Trust Company held 7,398 shares of Halozyme worth $478K as of Q1 2026.
  • Laird Norton Wetherby Trust Company sold 1,101 Halozyme shares in Q1 2026, an estimated $77.6K.
  • Halozyme made up 0.01% of Laird Norton Wetherby Trust Company's portfolio in Q1 2026, its #703 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Halozyme in Q4 2025 and has held it in 2 quarters since.
  • Laird Norton Wetherby Trust Company's Halozyme position peaked at $572K in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2026, filed 15 May 2026.